These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2605969)

  • 1. Practical problems in interim analyses, with particular regard to estimation.
    Pocock SJ; Hughes MD
    Control Clin Trials; 1989 Dec; 10(4 Suppl):209S-221S. PubMed ID: 2605969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 5. A case for Bayesianism in clinical trials.
    Berry DA
    Stat Med; 1993 Aug; 12(15-16):1377-93; discussion 1395-404. PubMed ID: 8248653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stopping rules and long-term follow-up in phase III trials.
    Pignon JP; Arriagada R
    Lung Cancer; 1994 Mar; 10 Suppl 1():S151-9. PubMed ID: 8087505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethics and practice: alternative designs for phase III randomized clinical trials.
    Palmer CR; Rosenberger WF
    Control Clin Trials; 1999 Apr; 20(2):172-86. PubMed ID: 10227416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data monitoring committees and interim monitoring guidelines.
    Freidlin B; Korn EL; George SL
    Control Clin Trials; 1999 Oct; 20(5):395-407. PubMed ID: 10503800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ethics of randomised controlled trials: a matter of statistical belief?
    Hutton JL
    Health Care Anal; 1996 May; 4(2):95-102. PubMed ID: 10162773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.
    Shen W; Ning J; Yuan Y
    Stat Med; 2015 Jun; 34(13):2104-15. PubMed ID: 25756852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian interim analysis of randomised trials.
    Abrams KR; Jones DR
    Lancet; 1997 Jun; 349(9069):1911-2. PubMed ID: 9217779
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decision-theoretic evaluation of early stopping rules.
    Heitjan DF; Houts PS; Harvey HA
    Stat Med; 1992 Mar; 11(5):673-83. PubMed ID: 1594809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to the use of interim data analyses in clinical trials.
    Lewis RJ
    Ann Emerg Med; 1993 Sep; 22(9):1463-9. PubMed ID: 8363121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.